Vertex Pharmaceuticals unveiled more positive results on the drug its developing with Johnson & Johnson to treat Hepatitis C. CNBC's Mike Hu...
The FDA has approved Amylin's Byetta as a stand-alone diabetes drug. The company's CEO, Daniel Bradbury, discusses the approval and more wit...
Dendreon has completed its FDA submission for prostate cancer drug Provenge, reports CNBC's Mike Huckman.
Discussing the green energy push, with Jim Greenwood, Biotechnology Industry Org. pres. & CEO.
Mapping biotech's future, with H. Thomas Watkins, Human Genome Sciences Pres. & CEO
A look at the public health care developments, with Jim Greenwood, Biotechnology Industry Org. pres. & CEO.
Posts |
TOPIC : Biotechnology
28 Sep 2009
Biotech companies continued their rally today, with the biotech index up more than 35 percent in the last three months... Read More
25 Sep 2009
Stocks continued to struggle on Friday... Read More
23 Jun 2009
If the government takes a knife to Medicare, this company could escape cut-free... Read More
23 Jun 2009
Plus, get calls on biotech, retail and more.... Read More
4 Jun 2009
Tough economic times make it hard for Intuitive Surgical to do business, Cramer says... Read More
News |
TOPIC : Biotechnology
Thursday, 5 Nov 2009
Source: CNBC staff and wire reports
Wednesday, 30 Sep 2009
About CNBC | Site Map | Privacy Policy | Terms of Service | Video Reprints | Advertise | Help | Contact
Partners: AOL Money | BloggingStocks.com
Partners: AOL Money | BloggingStocks.com
Data is a real-time snapshot *Data is delayed at least 15 minutesGlobal Business and Financial News, Stock Quotes, and Market Data and Analysis
© 2009 CNBC, Inc. All Rights Reserved.
A Division of NBC Universal
